Ad is loading...
BHVN
Price
$44.39
Change
-$4.27 (-8.78%)
Updated
Nov 15 closing price
123 days until earnings call
TRML
Price
$25.36
Change
-$1.52 (-5.65%)
Updated
Nov 15 closing price
Ad is loading...

BHVN vs TRML

Header iconBHVN vs TRML Comparison
Open Charts BHVN vs TRMLBanner chart's image
Biohaven
Price$44.39
Change-$4.27 (-8.78%)
Volume$1.28M
CapitalizationN/A
Tourmaline Bio
Price$25.36
Change-$1.52 (-5.65%)
Volume$173.37K
CapitalizationN/A
BHVN vs TRML Comparison Chart
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BHVN vs. TRML commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a Sell and TRML is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BHVN: $44.39 vs. TRML: $25.36)
Brand notoriety: BHVN and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 118% vs. TRML: 71%
Market capitalization -- BHVN: $4.49B vs. TRML: $650.3M
BHVN [@Biotechnology] is valued at $4.49B. TRML’s [@Biotechnology] market capitalization is $650.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 6 TA indicator(s) are bullish while TRML’s TA Score has 4 bullish TA indicator(s).

  • BHVN’s TA Score: 6 bullish, 4 bearish.
  • TRML’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BHVN is a better buy in the short-term than TRML.

Price Growth

BHVN (@Biotechnology) experienced а -16.98% price change this week, while TRML (@Biotechnology) price change was -11.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BHVN is expected to report earnings on Mar 20, 2025.

TRML is expected to report earnings on Mar 15, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($4.49B) has a higher market cap than TRML($650M). BHVN YTD gains are higher at: 3.715 vs. TRML (-3.132). TRML has higher annual earnings (EBITDA): -60.98M vs. BHVN (-774.44M). BHVN has more cash in the bank: 437M vs. TRML (290M). TRML has less debt than BHVN: TRML (333K) vs BHVN (29.7M). BHVN (0) and TRML (0) have equivalent revenues.
BHVNTRMLBHVN / TRML
Capitalization4.49B650M691%
EBITDA-774.44M-60.98M1,270%
Gain YTD3.715-3.132-119%
P/E RatioN/AN/A-
Revenue00-
Total Cash437M290M151%
Total Debt29.7M333K8,919%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BHVNTRML
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 6 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MZZ9.360.18
+1.96%
ProShares UltraShort MidCap400
TRTY25.79N/A
-0.02%
Cambria Trinity ETF
BLDG26.07-0.01
-0.04%
Cambria Global Real Estate ETF
FDHY48.74-0.11
-0.23%
Fidelity Enhanced High Yield ETF
IEV52.92-0.21
-0.40%
iShares Europe ETF

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
-8.78%
VCYT - BHVN
43%
Loosely correlated
-2.97%
APGE - BHVN
40%
Loosely correlated
-7.36%
ACLX - BHVN
39%
Loosely correlated
-7.63%
XENE - BHVN
38%
Loosely correlated
-4.60%
ABSI - BHVN
36%
Loosely correlated
-5.80%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-5.65%
SPHDF - TRML
78%
Closely correlated
N/A
SLRN - TRML
38%
Loosely correlated
-9.11%
IMNM - TRML
37%
Loosely correlated
-11.09%
BHVN - TRML
36%
Loosely correlated
-8.78%
NMRA - TRML
34%
Loosely correlated
-7.27%
More